NASDAQ:SRPT

Sarepta Therapeutics SEC Filings & 10K Form

$86.00
-0.75 (-0.86 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$84.75
$86.78
50-Day Range
$69.38
$86.75
52-Week Range
$67.68
$181.83
Volume1.13 million shs
Average Volume1.74 million shs
Market Capitalization$6.86 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.47

Sarepta Therapeutics (NASDAQ:SRPT) SEC Filings

DateFilerForm TypeView
05/18/2021
7:57 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2021
7:52 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2021
3:16 PM
Sarepta Therapeutics (Filer)
Form DEFA14A
03/10/2021
7:04 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
7:03 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
7:02 PM
O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
Form 4/A
03/10/2021
7:01 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4/A
03/10/2021
7:01 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4/A
03/10/2021
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4/A
03/05/2021
7:06 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:05 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:05 PM
O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:04 PM
Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:04 PM
MARTIN JOHN C (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:03 PM
GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:03 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:02 PM
Ciambrone William (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:02 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:01 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:00 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
7:00 PM
Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/16/2021
10:40 AM
SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G
02/12/2021
7:00 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/10/2021
11:30 AM
Capital Research Global Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
02/10/2021
11:26 AM
Capital Research Global Investors (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G
02/01/2021
7:23 AM
BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
01/11/2021
9:32 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2021
4:03 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
7:00 PM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
7:05 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
7:03 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
7:01 PM
Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/14/2020
7:00 PM
Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/14/2020
7:00 PM
Bratica Joseph (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
7:55 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2020
7:24 PM
GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
7:23 PM
Bratica Joseph (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
3:09 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/25/2020
4:06 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
4:22 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2020
7:00 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
7:00 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
7:00 PM
Bratica Joseph (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
7:00 PM
Bratica Joseph (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2020
7:00 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
7:40 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2020
8:17 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
8:18 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
8:05 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2020
7:00 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
8:02 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
3:02 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/21/2020
3:19 PM
Sarepta Therapeutics (Filer)
Form DEF 14A
04/08/2020
3:25 PM
Sarepta Therapeutics (Filer)
Form PRE 14A
03/06/2020
7:01 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:07 PM
GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:06 PM
BONNEY MICHAEL W (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:05 PM
Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:04 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:04 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:03 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:02 PM
MARTIN JOHN C (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:02 PM
O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:01 PM
Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:01 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
7:00 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
7:30 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2020
6:32 AM
BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
Form SC 13G/A
01/21/2020
7:00 PM
MARTIN JOHN C (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2020
11:31 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:41 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2020
7:00 PM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:02 PM
Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:01 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:00 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
6:59 PM
GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
7:01 PM
Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
3:25 PM
Sarepta Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
11/20/2019
7:34 PM
Ciambrone William (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
7:32 PM
Ciambrone William (Reporting)
Sarepta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2019
3:03 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/04/2019
7:40 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
7:00 AM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
4:17 PM
Sarepta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/09/2019
1:18 PM
BONNEY MICHAEL W (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
1:13 PM
BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
6:20 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
4:43 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2019
3:33 PM
Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
3:38 PM
Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
4:48 PM
INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:22 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:02 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/07/2019
4:00 PM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2019
7:07 PM
O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
7:03 PM
Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:02 PM
Sarepta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2019
3:39 PM
Sarepta Therapeutics (Filer)
Form DEFA14A
04/26/2019
3:22 PM
Sarepta Therapeutics (Filer)
Form DEF 14A
04/05/2019
7:30 AM
Sarepta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.